Mettler-Toledo International Inc.
NYSE:MTDMedical - Diagnostics & Research
+$16.60 today
- Market cap
- $34.55B
- Beta
- 1.26
- P/E (TTM)
- 26.6
- EPS (TTM)
- $43.14
Volume 0.16M
Average 0.19M
MTD Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Mettler-Toledo International Inc.NYSE: MTD
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 16.9% from a year ago
Cash & equivalents stood at $51.38M at the end of Q2 FY2026, down 16.9% from a year earlier and down 15.2% from the prior quarter. Over 3 fiscal years it compounded at -11.3% a year.
Context
- Cash & equivalents amounted to 1.4% of total assets at the end of Q2 FY2026, down 0.4 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -16.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 66.89M USD
- Year-over-year change
- +12.7%
- 4-year CAGR
- -9.2%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 66.89M | +12.7% |
| FY2024 | 2024-12-31 | 59.36M | -15.0% |
| FY2023 | 2023-12-31 | 69.81M | -27.3% |
| FY2022 | 2022-12-31 | 95.97M | -2.6% |
| FY2021 | 2021-12-31 | 98.56M | — |
Cash & Equivalents vs competitors
How MTD compares with its peers on the latest reported figures
- MTD's Jun 2026 cash & equivalents of $51.38M is the lowest of the 10 companies compared; the peer median is $621.3M.
- Its year-over-year change of -16.9% is the lowest of 10, against a peer median of +46.8%.
- Cash & equivalents amounts to 1.4% of total assets for MTD, versus a peer median of 4.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $5.68B | +271.9% | -8.4% | 6.1% | |
| Sep 2026 | $5.46B | +175.5% | +4.9% | 4.8% | |
| Jul 2026 | $1.76B | +14.5% | +19.3% | 12.6% | |
| Jul 2026 | $1.02B | +3.1% | +26.5% | 8.5% | |
| Jun 2026 | $621.3M | +9.3% | +10.5% | 9.0% | |
| Sep 2026 | $562.4M | +6.4% | -18.0% | 3.6% | |
| Jul 2026 | $539M | +46.8% | +6.9% | 2.2% | |
| Jun 2026 | $184.9M | +101.0% | -22.6% | 3.1% | |
| Oct 2026 | $149.22M | +67.2% | +56.1% | 4.7% | |
| Jun 2026 | $51.38M | -16.9% | -11.3% | 1.4% | |
| Peer median (excluding MTD) | $621.3M | +46.8% | +6.9% | 4.8% | |
Competitors are the stored peer set for MTD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 98.56M | 95.97M | 69.81M | 59.36M | 66.89M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 647.34M | 709.32M | 663.89M | 687.11M | 778.24M |
| Inventory | 414.54M | 441.69M | 385.87M | 342.27M | 387.23M |
| Other Current Assets | 108.92M | 128.11M | 110.64M | 105.16M | 130.31M |
| Total Current Assets | 1.27B | 1.38B | 1.23B | 1.19B | 1.36B |
| Property, Plant & Equipment (Net) | 799.37M | 778.6M | 803.37M | 770.28M | 845.64M |
| Goodwill | 648.62M | 660.17M | 670.11M | 668.91M | 739.23M |
| Intangible Assets | 307.45M | 306.05M | 285.43M | 257.14M | 278.91M |
| Long-term Investments | 2.12M | 6.89M | 0 | 398K | 0 |
| Tax Assets | 39.5M | 27.08M | 31.2M | 34.59M | 41.38M |
| Other Non-current Assets | 260.39M | 338.51M | 335.24M | 314.77M | 444.83M |
| Total Non-current Assets | 2.06B | 2.12B | 2.13B | 2.05B | 2.35B |
| Total Assets | 3.33B | 3.49B | 3.36B | 3.24B | 3.71B |
| Account Payables | 272.91M | 252.54M | 210.41M | 215.84M | 266.63M |
| Short-term Debt | 131.77M | 135.33M | 220.74M | 212.44M | 99.04M |
| Tax Payables | 134.77M | 191.1M | 219.98M | 193.33M | 201.18M |
| Deferred Revenue | 192.65M | 192.76M | 202.02M | 204.17M | 229.38M |
| Other Current Liabilities | 172.62M | 170.75M | 160.31M | 152.45M | 196.19M |
| Total Current Liabilities | 1.15B | 1.15B | 1.18B | 1.17B | 1.2B |
| Long-term Debt | 1.58B | 1.91B | 1.89B | 1.83B | 2.17B |
| Deferred Tax Liabilities | 62.23M | 111.36M | 108.68M | 103.95M | 151.78M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 277.49M | 213.14M | 240.18M | 176.11M | 142.06M |
| Total Non-current Liabilities | 2.01B | 2.32B | 2.32B | 2.2B | 2.54B |
| Total Liabilities | 3.16B | 3.47B | 3.51B | 3.37B | 3.74B |
| Common Stock | 448K | 448K | 448K | 448K | 448K |
| Retained Earnings | 5.86B | 6.73B | 7.51B | 8.37B | 9.24B |
| Accumulated OCI | (255.22M) | (227.23M) | (319.82M) | (345.86M) | (359.16M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 171.42M | 24.79M | (149.94M) | (126.89M) | (23.64M) |
| Total Debt | 1.8B | 2.13B | 2.2B | 2.13B | 2.34B |
| Net Debt | 1.7B | 2.03B | 2.13B | 2.07B | 2.28B |
Mettler-Toledo International Inc.
NYSE:MTD
Intrinsic Alpha fair value
Locked
Current Price
$1,737.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.